Assessing the Impact of Global Price Interdependencies in a Global Pricing Strategy
Loading...
Authors
Richter, Anke
Subjects
Advisors
Date of Issue
2008
Date
Publisher
Adis Data Information BV
Language
Abstract
Documented launch delays and the ensuing debate over their underlying causes have focused on assessment from the individual country's perspective. Seen in a larger game theoretical framework this may cause problems, because although the countries see an individual game, the pharmaceutical firm sees a repeated linked game. The links are due to external reference pricing and parallel trade. Behaviours that are optimal in the single, individual game (for either the country or the pharmaceutical firm) may no longer be optimal when considering the global repeated game. A theoretical mixed integer linear model of the firm's launch and pricing decisions is presented along with examples wherein international price dependencies most likely played a role. This model can help countries understand the implication of their external reference pricing policies on the global repeated pricing game. Understanding the behaviour of the pharmaceutical firm in this global context aids countries in designing policies to maximize the welfare of their citizens.
Type
Article
Description
Series/Report No
Department
Business & Public Policy (GSBPP)
Organization
Identifiers
NPS Report Number
Sponsors
Funder
Format
11 p.
Citation
Richter, Anke. "Assessing the Impact of Global Price Interdependencies." PharmacoEconomics 26.8 (2008): 649.
Distribution Statement
Rights
This publication is a work of the U.S. Government as defined in Title 17, United States Code, Section 101. Copyright protection is not available for this work in the United States.